| 青光眼视神经保护治疗的研究进展 |
| |
| 引用本文： | 刘兵,马晓华.青光眼视神经保护治疗的研究进展[J].国际眼科杂志,2010,10(11):2137-2140. |
| |
| 作者姓名： | 刘兵 马晓华 |
| |
| 作者单位： | 1. 山东中医药大学,中国山东省济南市,250014
2. 山东施尔明眼科医院,中国山东省济南市,250002 |
| |
| 摘 要： | 青光眼是由于眼压升高引起视乳头损害和视野缺损的一种致盲性眼病,其病理基础是视网膜神经节细胞及其轴突的进行性丢失。过去大量的研究都集中在降低眼压方面,现在视神经保护治疗作为一种通过阻止神经元死亡治疗青光眼的新策略已被普遍接受。我们从NMDA受体拮抗剂、神经营养因子、热休克蛋白、免疫系统等方面,总结了目前青光眼视神经保护治疗的研究进展。
|
| 关 键 词： | 青光眼 视神经保护 |
Research advances of optic nerve protection of glaucoma |
| |
| Bing Liu and Xiao-Hua Ma.Research advances of optic nerve protection of glaucoma[J].International Journal of Ophthalmology,2010,10(11):2137-2140. |
| |
| Authors: | Bing Liu and Xiao-Hua Ma |
| |
| Affiliation: | Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong Province, China;Shandong Shierming Eye Hospital,Jinan 250002,Shandong Province,China |
| |
| Abstract: | ·Glaucoma is one kind of blinding ophthalmopathy caused by increased intraocular pressure(IOP),and its pathologic basis is the progressive loss of retinal ganglion cells(RGCs)and its axons.In the past,a great number of studies have focused on reducing IOP.Now optic nerve protection is accepted generally as a new strategy for treating glaucoma by preventing the death of RGCs.This review summarizes the findings of experimental research on neuroprotection for glaucoma.· |
| |
| Keywords: | glaucoma optic nerve protection |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《国际眼科杂志》浏览原始摘要信息 |
|
点击此处可从《国际眼科杂志》下载全文 |
|
